Development of a novel combination of anti-septic taurolidine encased in a digestible nanoparticle system for use as topical treatment at burn sites…
Ended Project Grant Awarded Last action
- Award ID
- R43GM122156
- Recipient
-
Cormedix Inc. UEI K6BBWLG82PM3
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $274,469
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- Bedminster, NJ 07921, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$7,025 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $57,116 | |
| Amendment | $224,378 | |
| Amendment | -$224,378 | |
| Original award | $224,378 |
Quick answers
Who received award R43GM122156?
R43GM122156 was awarded to Cormedix Inc. by National Institute of General Medical Sciences (National Institutes of Health) on August 15, 2017.
How much is award R43GM122156 worth?
$274,469 has been obligated on R43GM122156.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award